Welcome to LookChem.com Sign In|Join Free

CAS

  • or

369-53-9

Post Buying Request

369-53-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

369-53-9 Usage

Uses

4-(Aminomethyl)benzamide is a trypsin inhibitor, and performs an antitrypsin activity.

Check Digit Verification of cas no

The CAS Registry Mumber 369-53-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,6 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 369-53:
(5*3)+(4*6)+(3*9)+(2*5)+(1*3)=79
79 % 10 = 9
So 369-53-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4H,5,9H2,(H2,10,11)

369-53-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Aminomethyl)benzamide

1.2 Other means of identification

Product number -
Other names 4-(aminomethyl)benzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:369-53-9 SDS

369-53-9Relevant articles and documents

Cobalt-based nanoparticles prepared from MOF-carbon templates as efficient hydrogenation catalysts

Murugesan, Kathiravan,Senthamarai, Thirusangumurugan,Sohail, Manzar,Alshammari, Ahmad S.,Pohl, Marga-Martina,Beller, Matthias,Jagadeesh, Rajenahally V.

, p. 8553 - 8560 (2018/11/30)

The development of efficient and selective nanostructured catalysts for industrially relevant hydrogenation reactions continues to be an actual goal of chemical research. In particular, the hydrogenation of nitriles and nitroarenes is of importance for the production of primary amines, which constitute essential feedstocks and key intermediates for advanced chemicals, life science molecules and materials. Herein, we report the preparation of graphene shell encapsulated Co3O4- and Co-nanoparticles supported on carbon by the template synthesis of cobalt-terephthalic acid MOF on carbon and subsequent pyrolysis. The resulting nanoparticles create stable and reusable catalysts for selective hydrogenation of functionalized and structurally diverse aromatic, heterocyclic and aliphatic nitriles, and as well as nitro compounds to primary amines (>65 examples). The synthetic and practical utility of this novel non-noble metal-based hydrogenation protocol is demonstrated by upscaling several reactions to multigram-scale and recycling of the catalyst.

PRODUCTION PROCESS OF AMINOMETHYL GROUP-CONTAINING BENZAMIDE COMPOUND

-

Page/Page column 12, (2008/06/13)

ABSTRACT There is provided a process for producing an aminomethyl group-containing benzamide compound represented by the general formula (II):wherein -CONH2 and -X represent a substituent on the benzene ring and -CONH2 exists at the meta- or para-position

5-Substituted-3-aminoalkyl indole derivatives

-

, (2008/06/13)

Compounds are disclosed of the general formula (I) STR1 wherein R1 represents halogen, alkyl, alkoxy or hydroxyl, or a group NRa Rb or CONa Rb, where Ra and Rb are hydrogen, alkyl or alkenyl or with the nitrogen atom form a saturated monocyclic 5 to 7-membered ring; R2 represents hydrogen or alkyl; R3 and R4 represent hydrogen, C1-3 alkyl or propenyl or R3 and R4 together form an aralkylidene group; Alk represents a C2-3 alkylene chain; n and m, are integers of 1 to 4 or n is zero, and their physiologically acceptable salts and solvates. The compounds are described as useful in treating pain originating from dilatation of the cranial vasculature in particular migraine and cluster headache and can be formulated in conventional manner as pharmaceutical compositions with carriers or excipients for administration by any convenient route.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 369-53-9